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Abstract 
Eating disorders are among the most challenging disorders to treat, with even state-of-the-art 
cognitive behavioral treatments achieving only modest success rates. One possible reason for the high 
rate of treatment failures for eating disorders is that existing treatments fail to attend sufficiently to 
critical aspects of the disorder such as experiential avoidance, poor experiential awareness, and lack of 
motivation.  These variables are explicit targets of acceptance and commitment therapy (ACT) and as 
such this approach may represent an ideal intervention for eating disorders. However, ACT has not 
been well investigated in this population. The current study sought to examine the efficacy of an ACT 
treatment group for eating disorders by examining whether the addition of ACT groups to treatment as 
usual (TAU) at a residential treatment facility for eating disorders will improve treatment outcomes. 
Results indicated that individuals in the ACT condition trended towards lower levels of eating 
pathology at post-treatment and showed significant reductions in bulimic symptoms and lower rates of 
inpatient treatment by follow-up. Some preliminary evidence suggests that Anorexia Spectrum 
patients may have done better in the ACT condition compared to Bulimia Spectrum patients. Other 
moderation analyses suggested that session attendance and higher levels of ACT consistent variables 
at baseline predicted a better response to ACT treatment. Although most mediation analyses were not 
significant, a small proportion suggested that willingness to experience distress was more highly 
associated with treatment outcome for the ACT condition. Overall, results suggest that ACT could be 
a viable treatment option for individuals with eating pathology and more study of ACT as an 
individual treatment is warranted. 
 8 
CHAPTER 1: INTRODUCTION 
1.1 Current Treatments for Eating Disorders 
  Eating disorders are exceptionally difficult to treat, particularly among adult patients with a 
long course of illness. These disorders tend to be ego-syntonic, with many individuals presenting for 
treatment with extreme ambivalence (Fairburn, 2008).  Despite the fact that eating disorders cause a 
severe reduction in quality of life, many individuals are reluctant to stop using disordered eating 
behaviors because they fear weight gain and increased body dissatisfaction, and have found that their 
eating disorder symptoms are powerfully able to reduce negative affect in the short term. This 
reluctance presents a significant challenge to the field of psychotherapy. Overall, there exist few 
empirically supported treatments for adult patients with bulimia, and those that are considered 
effective do not lead to symptom remission for a large portion of patients (NICE, 2004). For adults 
with anorexia, there are currently no empirically supported treatments (Wilson, 2007, Agras, et al., 
2004; Kaplan, 2002).  
1.1.1 CBT for Eating Disorders 
CBT is currently the treatment of choice for eating disorders (Fairburn, 2008). It is a 
transdiagnostic approach thought to be applicable to all eating disorders, although it is acknowledged 
that patients with anorexia tend to do less well than those with bulimia or binge eating disorder. The 
approach is primarily behavioral, with more traditional cognitive elements of CBT such as formal 
cognitive restructuring and thought records largely absent. Instead, treatment is focused on helping 
patients achieve cognitive change by changing their behavior and then analyzing the effects and 
implications of those changes. Although some cognitive work is utilized by helping patients displace 
their “eating disorder mindset,” and replace it with healthier thoughts and desires, it represents a 
smaller focus of treatment. Additional cognitive techniques focus on changing the overvaluation of 
shape, weight, and control over eating, and on learning to track and respond to mood-triggered 
changes in eating. The key foci of treatment are reducing dietary restraint and restriction, 
normalization of eating, and reaching and stabilizing at a normal weight.  Additional modules 
addressing topics such as perfectionism, mood regulation, core low self esteem, and interpersonal 
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problems are included are part of an enhanced treatment as needed for patients experiencing difficulty 
in these areas.  
Among patients with bulimia, CBT produces large reductions in binge eating, purging, and 
other compensatory behaviors (e.g., laxative/diuretic use, fasting; Fairburn, 2008; Treasure, et al., 
1994). Not only does CBT treatment produce rapid changes in the eating patterns of bulimic patients, 
but these changes tend to be well maintained over time (Waller, et al., 1996). Despite evidence that 
CBT is an effective treatment for bulimia, a large subset (30-50%) of patients still remain symptomatic 
enough to degrade quality of life (Fairburn, 2008; Wilson, 2005). In the case of anorexia, brief 
manualized CBT designed to treat eating disorders appears to have little efficacy, although this could 
be due to methodological limitations in the studies examining CBT for anorexia (McIntosh, et al., 
2005; Wilson, Grilo, & Vitousek, 2007).  Studies on this population have typically been small, poorly 
designed, and lacking in methodological rigor (Wilson & Fairburn, 1993; Wilson, et al., 2007). 
Overall, although CBT has been shown to result in statistically significant reductions in eating 
pathology, particularly for those with bulimia, there is clearly room for improvement.  
1.1.2. Reasons for limited effectiveness of current treatment 
A number of theoretical explanations exist for CBT’s limited efficacy with eating disorders. 
One explanation concerns the lack of motivation for treatment commonly found among most patients 
with anorexia and many patients with bulimia. Given the high ambivalence about change, a strong 
focus on changing disordered eating behaviors and removing the “eating disorder mindset” might be 
flawed (Vanderlinden, 2008).  Many of these patients may be reluctant to engage in any treatment with 
a direct agenda to modify eating disordered thoughts and therefore may never make the proposed 
behavior changes to the degree needed to modify distorted cognitions. Even if patients with an eating 
disorder are willing to try to restructure distorted cognitions, there is some evidence that cognitive 
restructuring is not effective for this population (Vanderlinden, 2008). Due to the difficulties in 
controlling distressing food-related thoughts and urges, as well as distressing thoughts about other life 
stressors that may trigger food-related thoughts, it may be beneficial for patients to learn how to 
change their “relationship” to these thoughts, rather than changing the thoughts themselves. Instead of 
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learning how to displace the “eating disorder mindset,” patients could be taught how to resist urges to 
use disordered eating behaviors despite having urges to purge or restrict. Patients might be taught to 
accept the presence of troubling thoughts and feelings, and to give up attempts to control, alter, or 
avoid these thoughts, including through the use of eating disorder behavior.  One type of therapy that 
may be able to address some of the limitation of existing CBT programs for eating disorders is 
acceptance and commitment therapy (ACT).  
1.2. Acceptance and Commitment Therapy  
ACT is one of several newer, acceptance-based models of CBT (Forman & Herbert, 2009).  
When compared to more traditional forms of CBT such as Beckian cognitive therapy, acceptance-
based behavioral therapies focus on acceptance of distressing cognitions, with the emphasis on 
changing behaviors rather than internal experiences (Hayes, Masuda, Bissett, Luoma, & Guerrero, 
2004). Because ACT theorists believe that the content of internal experiences is largely outside of 
voluntary control, the therapy focuses on teaching patients to become more accepting of unwanted 
internal experiences. Experiential avoidance, or efforts to avoid distressing internal experiences, is 
thought to be at the root of much psychological suffering (Hayes, et al., 2004). Although experiential 
avoidance may allow the patient to temporarily reduce his or her discomfort, it rarely works as a long-
term strategy. Ultimately, experiential avoidance promotes “psychological inflexibility,” as patients 
who are trying to avoid distressing thoughts and feelings are less able to take behavioral steps that are 
needed to live a valued life. Therefore, patients are encouraged to clarify their values and create goals 
that can help them live a more meaningful life. The strong focus on encouraging patients to live a 
valued life and to take committed action towards goals helps increase motivation for treatment and 
provides a rationale for decreasing experiential avoidance (Hayes & Pankey, 2002). Ultimately, the 
goal of an ACT treatment is to increase psychological flexibility, or the extent to which patients can 
alter their behaviors based on what is needed to live according to their values (Herbert, Forman, & 
England, 2009). Although many of the skills taught in ACT are cognitive, a strong emphasis is placed 
on using the cognitive skills to work on and achieve behavioral goals. Within an ACT framework, 
most behavioral strategies can be employed, and should be a strong emphasis of treatment.  
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1.2.1. Research on ACT 
ACT is currently considered an efficacious treatment for a variety of disorders, and has an 
active body of research dating back to the early 1990’s. Currently there are over 50 published 
treatment studies demonstrating efficacy for a variety of health concerns (Gifford, et al., 2004; Gregg, 
2004; McCracken & Eccleston, 2006) and disorders (Bach & Hayes, 2002; Dalrymple & Herbert, 
2007; Twohig, Hayes, & Masuda, 2006; Woods, Wetterneck, & Flessner, 2006).  A meta-analysis 
conducted in 2006 demonstrated that overall, ACT was more effective than control conditions, and 
that its efficacy was on par with and occasionally surpassed standard CBT (Hayes, Luoma, Bond, 
Masuda, & Lillis, 2006). Additional meta-analyses have found that ACT is consistently better than 
control conditions and on par with established treatments (Powers, Zum Vorde Sive Vording, & 
Emmelkamp, 2009). However, ACT’s effectiveness at treating eating disorders remains relatively 
unstudied.   
1.3  ACT for Eating Disorders 
1.3.1. ACT for Eating Disorders: Evidence 
Despite the lack of treatment outcome research, there are suggestions that ACT may be an 
effective treatment for this population. Beginning in 2002 a series of case studies and response papers 
were published by leaders in the ACT field arguing that eating disorders may be an ideal target for an 
ACT treatment (Hayes & Pankey, 2002; Heffner, Sperry, Eifert, & Detweiler, 2002; Orsillo & Batten, 
2002). Several other researchers have noted the conceptual fit between ACT and eating disorders, and 
have demonstrated how ACT could be used for this population (Heffner & Eifert, 2004; Merwin & 
Wilson, 2009, Merwin, Timko, Moskovich, Konrad, Zucker, & Bulik, in press). Empirically, small 
pilot studies of new acceptance-based therapies such as dialectical behavioral therapy (Safer, Telch, & 
Chen, 2009), mindfulness-based cognitive therapy (Kristeller, Baer, & Quillian-Wolever, 2006), and 
functional contextual treatment  (Anderson & Simmons, 2008) have demonstrated promise for 
treatments binge eating and bulimia. A series of case reports have also indicated that ACT treatment 
could benefit patients with treatment-resistant anorexia (Berman, Boutelle, & Crow, 2009).  Moreover, 
a study comparing ACT and traditional CBT for the treatment of co-morbid disordered eating found 
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that ACT was the more successful treatment (Juarascio, Forman, & Herbert, 2010). The results 
indicated that CT produced modest decreases in eating pathology whereas ACT produced large 
decreases. However the study employed a small post-hoc design of sub-threshold patients, making it 
difficult to generalize these findings to patients with a diagnosable eating disorder. In addition to the 
small evidence base suggesting ACT may be a useful treatment for eating disorders, there is also a 
large body of empirical work demonstrating that eating disorder symptoms are related to many key 
ACT variables.  
1.3.2. Acceptance/Experiential Avoidance 
One of the main reasons that ACT may be a good fit for the treatment of eating disorders is the 
high experiential avoidance commonly found in this population (Cockell, Geller, & Linden, 2002; 
Keyser et al., 2009; Mizes & Arbitell, 1991; Orsillo & Batten, 2002).  Eating disorders have long been 
conceptualized as disorders of control, with patients striving to control their shape, weight, and eating 
behavior (Fairburn, Shafran, & Cooper, 1999; Orsillo & Batten, 2002; Tiggemann & Raven, 1998). 
Many patients with an eating disorder also have a strong desire to control their internal experiences 
such as physical sensations, urges, thoughts, and feelings associated with the disorder and with life 
stressors (Merwin & Wilson, 2009).  It appears that eating disorder symptoms function as a way to 
help the patient avoid upsetting internal experiences (Hayes & Pankey, 2002; Keyser, et al., 2009; 
Paxton & Diggens, 1997, Serpell, Treasure, Teasdale, & Sullivan, 1999). Individuals may become 
hyperfocused on their body and food intake as a means of avoiding other upsetting thoughts or 
feelings that they believe are outside of their control. An ACT based treatment would attempt to 
disrupt this pattern of hyper-focus on the body and eating behavior so that novel behaviors can emerge 
and the individual can focus on the thought content she was originally avoiding (Merwin & Wilson, 
2009).  
Research has indicated that many eating disordered behaviors are used to avoid feelings of 
rejection, imperfection, failure, vulnerability, and intimacy (Hayes & Pankey, 2002; Keyser et al., 
2009; Paxton & Diggens, 1997; Pells, 2006). For example, individuals with bulimia nervosa report 
using purging as a means of avoiding the distressing cognitions associated with binge eating (Mizes & 
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Arbitell, 1991).  Bingeing allows an escape from aversive self-awareness (Heatherton & Baumeister, 
1991) and both under- or over-eating have been shown to remove upsetting internal experiences like 
boredom, depressed mood, and guilt (Davis & Jamieson, 2005; Macht, 2008).  Other types of 
compensatory behaviors function similarly, with laxatives, diuretics, diet pills, and fasting all helping 
the patient avoid fears such as “no one will love me if I gain weight” or “I am out of control”(Orsillo 
& Batten, 2002). Extreme caloric restriction and excessive exercise also can be conceptualized as 
forms of experiential avoidance that allow the patient to avoid distressing cognitions by promoting  
intense focus on the body instead of other emotions (Heffner, et al., 2002). 
 There is also some evidence that women with an eating disorder, particularly anorexia, may 
be temperamentally avoidant, and may attempt to avoid distressing emotions in all aspects of their 
lives (Schmidt & Treasure, 2006).  Engaging in disordered eating behaviors and focusing attention on 
the body is one way these individuals may avoid distressing internal experiences (Cockell, et al., 2002; 
Keyser, Sharma, et al., 2009; Mizes & Arbitell, 1991; Orsillo & Batten, 2002).  This avoidance likely 
contributes to psychological inflexibility, as these women are less able to behave in ways consistent 
with their values. Masuda and colleagues have indicated that psychological inflexibility is related to 
disordered eating amongst college students and that psychological flexibility mediates the link 
between disordered eating related cognition and non-specific psychological distress and ED 
symptoms, indicating that poor psychological flexibility is strong related to eating disordered behavior 
(Masuda, Price, Anderson, & Wendell, 2010).  Overall, both anorexia and bulimia are characterized by 
experiential avoidance, and the desire to maintain firm control over distressing thoughts and feelings 
that are not body or food related is ultimately responsible for many eating disordered behaviors 
(Merwin et al., 2010; Merwin & Wilson, 2009).  This high degree of experiential avoidance indicates 
that these patients may benefit from a treatment in which they could learn to adopt an attitude of 
acceptance towards internal experiences (Merwin & Wilson, 2009).  
1.3.3. Mindfulness 
Patients with eating disorders tend to be less aware of their emotions than healthy individuals 
(Merwin et al., in preparation; Merwin, Zucker, Lacy, & Elliot, 2009). Previous research has 
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demonstrated that individuals with eating disorders show deficits in emotion recognition and poor 
interceptive awareness (Harrison, Sullivan, Tchanturia, & Treasure, 2009; Zonnevylle-Bender, van 
Goozen, Cohen-Kettenis, van Elburg, de Wildt, et al., 2004; Zonnevylle-Bender, van Goozen, Cohen-
Kettenis, van Elburg, & van Engeland, 2004) and have poor emotional awareness (Gilboa-
Schechtman, Avnon, Zubery, & Jeczmien, 2006; Keyser, Pastelak, et al., 2009; Sim & Zeman, 2004). 
For example, some studies suggest that many eating disordered patients are unable to label their 
upsetting feelings, instead experiencing all negative emotions similarly (Sorenson & Mezo, 2009). 
 Researchers have also noted that social cognitions appears to be limited among those with 
particularly chronic forms of anorexia, and these patients show deficits in emotional recognition in 
others and constricted emotional expression (Zucker, et al., 2007). In addition, research has indicated 
that patients with bulimia and anorexia have high levels of alexithymia, and that it appears to be a trait 
that may be unaffected by clinical improvement unless emotional expression is taught in treatment 
(Schmidt & Treasure, 2006). Since many patients appear to have trouble recognizing what type of 
emotion they are experiencing, negative emotions in general are viewed as scary. Given the high harm 
avoidance among those with an eating disorder, most patients will try to avoid contact with these 
emotions.  Therefore, treatment may need to initially focus on teaching emotional recognition and 
identification skills, and subsequently on increasing non-judgmental awareness. Increased non-
judgmental awareness might allow for more psychological flexibility and help patients live a more 
valued life.  
1.3.4. Values 
Patients with eating disorders tend to have trouble identifying values unconnected with food 
and body image. In the process of developing this disorder, many patients lose touch with other areas 
of interest (Fairburn, 2008).  Most women with an eating disorder, and particularly those with 
anorexia, tend to strongly value their disorder and find it to be ego-syntonic (Schmidt & Treasure, 
2006). These patients typically have poor clarity regarding non-eating related values, as their over-
valuation of shape, weight, and control over-eating becomes the predominant concern (Fairburn, 
2008). Poor values clarity can lead to the often ambivalent feelings many patients have towards 
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treatment.  Anorexia serves a variety of valued functions for the patient, for example helping patients 
feel safe, in control, confident, and to avoid uncomfortable feelings (Cockell, et al., 2002; Serpell et 
al., 1999). Values clarity may be particularly difficult to achieve in such a risk-averse population 
because they may fear caring about things that are less tangible or viewed as more difficult to achieve 
than a specific body shape or weight (Merwin & Wilson, 2009).  Some patients may even fear 
identifying values because doing so creates an expectancy that they will work on these areas, and this 
invokes the possibility of failure or other feared outcomes.  For many individuals, the overvaluation of 
shape and weight to the exclusion of other life areas is preferred, because the alternative values are 
viewed as unpredictable, scary, and difficult to control (Merwin & Wilson, 2009). 
This lack of clarity about non-weight related values is an important focus of ACT treatment, 
and could potentially help to motivate previously ambivalent patients.  Helping the patient identify 
what her eating disorder has cost her and clarifying what she truly wants her life to be about could 
increase the patient’s willingness to undergo the challenging work needed to make behavioral changes. 
Committed action might occur as patients learn to set concrete goals that are values consistent, and 
traditional behavioral approaches are integrated into treatment to help achieve this action. It is in this 
aspect that many of the techniques indicated by traditional CBT for eating disorders can be utilized, 
such as normalization of eating, binge analysis, and reducing dietary restraint and restriction. Other 
standard behavioral techniques such as exposure, skills acquisition, shaping methods, and goal setting, 
also fit well into an ACT protocol, and function as ways to help the patient achieve committed action.  
1.4. Current Study 
In sum, it has been argued that ACT is a good theoretical match for eating disorder pathology. 
Previous research has indicated that individuals with eating disorders tend to be highly experientially 
avoidant, have a strong desire to control their internal experiences, have low distress tolerance, poor 
emotional awareness, and lack clarity about their non-eating disordered values. Overall, they tend to 
be psychologically inflexible. Pilot studies have also indicated that mindfulness and acceptance appear 
to be useful additions to treatment, and that ACT is effective in reducing disordered eating in a sub-
clinical population. The current study sought to empirically investigate the efficacy and acceptability 
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of a group-based ACT treatment for a population of adult residential patients with an eating disorder. 
The study took place at a residential treatment facility for eating disorders in the Mid-Atlantic region 
of the United States. The primary goal of the study was to assess whether ACT plus treatment as usual 
(TAU) could produce larger reductions in disordered eating than TAU alone. TAU at the residential 
facility provided an intensive and comprehensive program of individual, group, and family therapy 
plus nutritional counseling. TAU at this residential facility has been shown to produce moderate to 
large changes in disordered eating at post-treatment; the effects were only mildly attenuated by follow-
up (Lowe, Davis, Annunziato, & Lucks, 2003). However, despite the large reduction in symptoms, the 
mean post-treatment levels of disordered eating and body dissatisfaction were still in the pathological 
or almost pathological range indicating that there is still substantial room for improvement.  ACT 
groups were offered in addition to all TAU to determine if this resulted in additional improvement in 
disordered eating.  
1.5. Hypotheses 
1. ACT will have good treatment acceptability.  
a. We hypothesized that ACT would be well liked by participants and would have 
adequate treatment acceptability (defined as a mean score of 30 or above on the 
Treatment Acceptability Questionnaire). We hypothesized that those in the TAU + 
ACT group (henceforth referred to as simply the ACT group) would have just as high 
or higher acceptability than TAU.  
2. ACT, compared to TAU alone, would result in larger decreases in disordered eating behavior 
and body image dissatisfaction, and larger increases in quality of life, at follow-up. An effect 
may be observable at post-treatment. 
a. Treatment as usual at The Renfrew Center’s residential facilities has been 
demonstrated to produce moderate to large changes in eating behavior at post-
treatment (Lowe, et al., 2003). Given the large effect sizes seen during TAU at post-
treatment, we may not see an effect of ACT groups until follow-up, where their eating 
disorder behaviors are under more voluntary control and are not as influenced by the 
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structural support at Renfrew. Despite efficacy at reducing disordered eating at post-
treatment, TAU at the Renfrew Center’s residential facilities demonstrate a reduced 
efficacy at follow-up, with many participants relapsing or demonstrating continued 
symptom use (Lowe, et al., 2003; O'Planick, personal communication). Previous work 
has demonstrated that the gains made in ACT treatments are stable across time 
(Hayes, et al., 2004), suggesting that patients may be less likely to relapse following 
an ACT based treatment.  
3. Eating disorder diagnosis will be a moderating variable at post-treatment and follow-up.  
a. Given the dearth of effective treatments for anorexia, it is possible that this disorder 
may remain more difficult to treat and individuals with anorexia may show smaller 
decreases in disordered eating and body image dissatisfaction than individuals with 
bulimia (Guarda, 2008; Kaplan, 2002). However, because ACT focuses on treating 
experiential avoidance and values clarity, which tend to be more pervasive amongst 
individuals with anorexia, it is possible that this treatment may be more effective for 
this diagnostic subgroup (Hayes & Pankey, 2002; Merwin & Wilson, 2009; Schmidt 
& Treasure, 2006).  
4.  The effect of ACT+ TAU at post-treatment may depend on dosage.  
a. Participants at the residential treatment facility were required to attend all ACT 
groups, but occasionally missed a group if they had visitors, were feeling sick, they 
were non-compliant with group attendance, or their therapist requested that they 
attend another group instead. In addition, the length of stay at the residential facility 
varied considerably, and some participants were not at the facility long enough to 
attend all groups. Therefore, the total number of groups attended varied. It could be 
that those who attended more groups showed a greater reduction in disordered eating, 
as these individuals had the most time to practice the skills taught in ACT. However, 
it is also possible that patients who were doing particularly well were dropped from 
insurance at an earlier time point, and therefore were actually less likely to attend a 
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large number of ACT groups. Therefore, we examined the effect of dosage on 
treatment, but did not have any preliminary hypotheses as to the direction of this 
effect.  
5. Baseline ACT variables will moderate the relationship between treatment condition and time 
in predicting outcome scores.  
a. A growing body of research has indicated that individuals who already demonstrate 
higher baseline levels of certain ACT variable such as acceptance or mindfulness 
(Herbert et al., 2010), are more likely to show benefits from an ACT based treatment. 
We hypothesized that individuals in our sample who had higher scores on our process 
variables at baseline and were in the ACT group would show the largest 
improvements.  
6.  Changes in core ACT variables such as acceptance, mindfulness, defusion, and values clarity 
will mediate improvement in eating disorder symptoms.  
a. Previous research that has examined mediators of treatment outcome with ACT for 
other kinds of psychopathology have found that the key variables of interest mediate 
treatment outcome for a variety of disorders (Forman, Herbert, Moitra, Yeomans, & 
Geller, 2007; Hayes, et al., 2004; Lappalainen, et al., 2007). This same finding was 
expected amongst a population with eating disorders. We also hypothesized that TAU 
and ACT cohorts would both show improvements in ACT related variables, but that 
those who attended ACT groups would show the largest improvements.  
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CHAPTER 2: METHODS 
2.1. Participants 
Participants were women between the ages of 18 and 65 who were residents at The Renfrew 
Center’s residential treatment facility in Philadelphia, Pennsylvania. Adolescents were excluded due to 
difficulties obtaining consent from their parents and because they had a different treatment schedule in 
the evenings such that they could not attend the ACT groups on a regular basis.  The Renfrew Center 
only admits women, and therefore there was no ability to enroll men in the study. The women had a 
diagnosis of anorexia, bulimia, or eating disorder not otherwise specified, anorexia or bulimia 
spectrum. There were no other exclusion criteria, and patients with other disorders were included in 
the study as long as their eating disorder was primary enough to warrant admission to The Renfrew 
Center. Participants were compensated for their participation in the study and for completing study-
related measures and did not need to pay any additional money to participate in the groups beyond 
costs associated with TAU at The Renfrew Center. All participants had the right to decline to 
participate in this study, and were still able to attend the ACT groups if they did not agree to complete 
study-related measures.  
A total of 159 women who met initial inclusion criteria were admitted to the Renfrew Center 
during the time period of data collection. Of the 159 who were approached to participate in the study, 
140 consented to take part in the study (TAUa: 20, ACT=66, TAUb=54). The average age of the 
sample was 26.74 (SD= 9.19), with a range of 18-55. The sample was predominantly Caucasian 
(89.3%, n=125), with small proportions of other racial groups (African American=3.6%, Asian=2.1%, 
Hispanic=2.9%, Other=1.4%). The sample has a relatively long eating disorder history (M= 10.75 
years, SD= 9.08) with an average age of onset at 16.43 (SD=5.5).  In conjunction with the long history, 
most participants had previously attended an inpatient or residential level of care (M=1.18 other stays, 
SD=2.18), with a range of 0-10 previous stays. The sample was relatively evenly split across eating 
disorder diagnoses. For the purpose of this study we grouped individuals into AN (47.1%, n=66) or 
BN (52.9%, n=74) spectrum diagnoses. All individuals at or below 85% of their ideal weight were 
categorized as AN spectrum and all patients who were above this weight and exhibited either bingeing 
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or compensatory behaviors were categorized as BN spectrum. If patients had just recently gained 
enough weight to place their percentage above 85% at another treatment facility, they were still 
considered AN spectrum. These categories have been used in previous studies, and appear to 
accurately distinguish between pathologies (Fairburn & Walsh, 2002; Walsh & Garner, 1997). Co-
morbidities were also high for the sample, with most individuals meeting criteria for at least one other 
psychiatric diagnosis, most commonly a depressive disorder (77.8%), generalized anxiety disorder 
(43.5%), and substance abuse (17%) or dependence (6.4%) disorder.  
2.2. Measures 
2.2.1  Disordered Eating and Body Image 
       Eating Disorder Inventory-3 (EDI-3; Garner, 2004). The EDI is a 91-item, 4-point forced-
choice inventory assessing several behavioral and psychological traits common in two eating 
disorders, bulimia and anorexia nervosa.  The EDI consists of 6 composite scores: Eating Disorder 
Risk, Ineffectiveness, Interpersonal Problems, Affective Problems, Overcontrol, General 
Psychological Maladjustment. For this study, the Eating Disorder risk composite score, which assesses 
drive for thinness, bulimia, and body dissatisfaction was assessed along with all three individual 
subscales that comprise this scale. The Eating Disorder Risk Composite reliability ranges from .90-.97 
(median = .94) across four diagnostic groups and three normative groups and has a test-retest 
coefficient of .98. Cronbach’s alpha for the current study was .93 for the Eating Disorder Risk 
Composite Scale. 
 Eating Disorder Examination Questionnaire (EDE-Q; Fairburn & Beglin, 1994). The EDE-Q 
is a self-report
 
version of the Eating Disorder Examination interview. It has
 
a 4-week time period, and 
it assesses the core features of eating
 
disorders. Four subscales may be derived from the instrument,
 
together with a global score:  Restraint, Weight Concern, Shape Concern, and Eating Concern. It also 
assessed occurrence and frequency of eating disorder symptoms. Performance on the EDE-Q has been 
extensively studied, both in isolation and in comparison
 
with the EDE interview.
 
The findings indicate 
that in many respects the EDE-Q is a reasonable substitute for the
 
EDE interview (Mond, Hay, 
Rodgers, Owen, & Beumont, 2004a, 2004b). Internal consistency and test-retest reliability are both 
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excellent (Luce & Crowther, 1999). Cronbach’s alpha for the current study was .91 for the Global 
subscale. 
 Structured Clinical Interview for DSM disorders (SCID; First, Spitzer, Gibbon, & Williams, 
2002).   The SCID is a diagnostic exam used to determine DSM-IV Axis I disorders. For this study, 
we will only be administering the eating disorders section of the SCID to diagnose anorexia, bulimia, 
or EDNOS. Reliability for the eating disorder section of the SCID has shown acceptable inter-rater 
and test-retest reliability (Zanarini, et al., 2000).   
2.2.2  Defusion 
Drexel Defusion Scale (DDS; Herbert, Forman, & Moitra, 2008). The DDS is a self-report 
questionnaire assessing the extent to which a person is able to distance him/herself from negative 
thoughts, feelings, and physiological reactions. The measure begins with a 3-paragraph definition of 
defusion, and is followed by ten items presenting common scenarios that elicit negative internal 
experiences. Defusion is explicitly assessed in each of the following domains: feelings of anger, 
cravings for food, physical pain, anxious thoughts, thoughts of self, thoughts of hopelessness, thoughts 
about motivation or ability, thoughts about one’s future, sensations of fear, and feelings of sadness. It 
has been demonstrated to have acceptable reliability (Herbert, et al., 2008). Cronbach’s alpha for the 
current study was .83. 
Eating Attitudes Thoughts and Defusion Scale (EATDS; unpublished). The EATDS is a 
measure of how well a person is able to distance herself from negative thoughts about food, weight, 
and body image. The measure follows a similar style to the DDS, but is a more focused version based 
on eating and weight related thought content. There are no psychometric data available for this 
measure. Cronbach’s alpha for the current study was .91 for the frequency scale and .96 for the 
defusion scale. The frequency score was calculated by summing the frequency reported for the 13 
items. The defusion scale was calculated by averaging the defusion scores for the items that were 
given a frequency higher than zero.  
2.2.3. Psychological Acceptance    
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The Philadelphia Mindfulness Scale (PHLMS; Cardaciotto, Herbert, Forman, Moitra, & 
Farrow, 2008).  The PHLMS is a 20-item self-report measure designed to assess mindfulness, defined 
by two primary components: present-moment awareness and nonjudgmental acceptance. Exploratory 
and confirmatory factor analyses support the two-factor structure. Both the awareness and the 
acceptance subscale will be used to assess mindfulness and psychological acceptance respectively.  
Good internal consistency and reliability was demonstrated in both clinical and non-clinical samples 
(Cardaciotto, et al., 2008). Cronbach’s alpha for the current study was .82. 
 Acceptance and Action Questionnaire-II (AAQ-II; Bond, et al., in press). The AAQ is a 
measure of psychological flexibility. It assesses experiential avoidance, or the tendency to avoid 
unwanted internal experiences and willingness to engage in behaviors despite unpleasant internal 
experiences. It has demonstrated adequate reliability and validity (Bond, et al., in press). Cronbach’s 
alpha for the current study was .92. 
2.2.4.  Valued Living and Quality of Life 
 Valued Living Questionnaire II (VLQ-II; Wilson, Sandoz, Kitchens, & Roberts, in press). The 
VLQ-II is designed to assess how strongly a participant values several areas of life such as family 
relations, education, work, friends, etc. The VLQ-II is most commonly used as a clinical measure, and 
scoring instructions are not yet validated. In the current study, 4 subscales will be used:  Importance of 
valued domains, Current action taken towards valued domains, Satisfaction with current action, and a 
composite score that combined importance and satisfaction.  
Eating Disorder Quality of Life Scale (EDQOL; Engel, et al., 2006). The EDQOL is a 
condition-specific quality of life measure for use with adolescents and adults with eating disorder. It is 
a 25 item measure that assesses 4 domains: Psychological, Physical/Cognitive, Work/School, and 
Finance. A total score can also be calculated. It has demonstrated excellent psychometric properties 
(Engel, et al, 2006). Cronbach’s alpha for the total score was .89 for the current study.  
2.2.5 Emotion Regulation 
 Difficulties in Emotion Regulation (DERS; Gratz & Roemer, 2004). The DERS is a 36-item 
multidimensional self-report measure assessing individuals’ characteristic patterns of emotion 
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regulation. It contains six subscales that were theoretically formulated and confirmed through factor 
analysis. The six subscales are: Nonacceptance of Emotional Responses , Difficulties Engaging in 
Goal-Directed Behavior, Impulse Control Difficulties, Lack of Emotional Awareness, Limited Access 
to Emotion Regulation Strategies, and Lack of Emotional Clarity. Preliminary empirical studies have 
demonstrated good overall internal consistency and adequate subscale reliability with Cronbach’s > 
.80 for each subscale (Gratz & Roemer, 2004). Cronbach’s alpha for the current study ranged from .91 
to .95 for the subscales. 
2.2.6 Depression 
 Goldberg Depression Scale (GDS; Goldberg, Bridges, Duncan-Jones, & Grayson, 1988). The 
GDS is an 18 item measure designed to assess depression. Overall, this measure has demonstrated 
acceptable internal and external validity and acceptable internal consistency (Holm, Holm, & Bech, 
2001). Cronbach’s alpha for the current study was .92. 
2.2.7 General Symptoms 
 Brief Symptom Questionnaire (BSQ, unpublished). The BSQ is a measure of eating disorder 
symptoms, depression, anxiety, and multiple ACT related variables. It was created specifically for this 
study to quickly assess changes in disordered eating, mood, and process variables during treatment, 
but was based on a similar measure designed for use amongst anxious and depression patients 
(Forman, Chapman, Herbert, Goetter, Yuen, & Moitra, in press). In the current study, only the process 
variables were utilized. These questions assessed changes in acceptance, willingness, defusion, and 
other ACT related measures using a single item.  As each item on the measure it not necessarily 
related to other items, no Cronbach’s alpha was calculated.  
2.2.8. Treatment Acceptability 
 Treatment Acceptability Questionnaire (TAQ, unpublished). The TAQ was created for the 
current study to assess treatment acceptability in both the TAU and ACT conditions. Participants were 
instructed to answer in response to the entire treatment package they received while at Renfrew. The 
measure contained 6 items rated on a Likert scale from 1-7, with seven being the highest level of 
treatment acceptability. Domains included acceptability (question 1), morality (question 2), 
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effectiveness (question 3), negative side effects (question 4), knowledge of staff (question 5), and 
trustworthiness (question 6).  
2.3. Procedure 
The study was approved by the Institutional Review Board at Drexel University and by the 
Core Research Committee at the Renfrew Center. Due to the nature of treatment at Renfrew, random 
assignment was not feasible. Therefore, the study utilized a three-wave ABA design, with the first 
wave (A) receiving TAU, the second wave (B) receiving TAU +ACT, and the third wave (A) 
receiving TAU.  An ABA design allowed for a comparison of TAU both before and after 
administration of the ACT groups to provide greater certainty that any increases in treatment gains 
shown during ACT groups was not due to other changes in programming at the residential facility. If 
treatment gains are higher during ACT than in both TAU phases, we can be relatively confident that 
this was due to the addition of the ACT groups, even though random assignment could not be used.  
2.3.1.  Assessments 
Assessments occurred at pre-treatment, post-treatment, and at 6-month follow-up for both the 
TAU and ACT waves.   All patients who were over the age of 18 and admitted to the treatment 
facility were approached within three days of their admit date by a member of the research team to 
determine if they would be interested in participating in the study and to review the consent form. If 
the patient did consent to being part of the treatment study, she underwent a 1-hour pre-treatment 
assessment at this time. This included a food challenge task, a brief structured interview, and a 
questionnaire packet including all ACT process variables.  
Additional questionnaires were given during the standard assessment procedures 
implemented by The Renfrew Center. Patients at Renfrew undergo a standard assessment upon 
admission, discharge, and at 6-month follow-up. This standard assessment included the eating 
disorder specific measures. The semi-structured interview was conducted using the eating disorder 
section of the Structured Clinical Interview for DSM Disorders (SCID). In addition to the 
administration of all the measures listed above, patients underwent a food challenge task in which the 
patient was asked to eat as much of a challenge food as she was willing to eat. The food challenge 
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task will not be analyzed as part of the current study. The same assessment battery occurred at the 
post-treatment mark, which was defined as between five and zero days before discharge.  The follow-
up assessment consisted solely of the questionnaire packet. This was emailed to participants 6 
months after their discharge from The Renfrew Center. In addition to the pre-treatment, post-
treatment, and follow-up assessments, we also administered the Brief Symptom Questionnaire (BSQ) 
weekly.  
Although process measures were given at all three time points, the retention rate by follow-
up for this series of measures was low (n=31). A series of independent measures analyses suggested 
that those who completed the follow-up ACT measures had more severe eating pathology at baseline 
on several subscales (EDE global, EDE shape concern, and EDI bulimia), and showed an overall 
poorer response to treatment. Because the data for process variables at follow-up did not appear to be 
representative, these data were not used for additional analyses. 
2.3.2.  TAU 
Patients in the TAU condition were informed that they were in the TAU condition after they 
consented to take part in the study. TAU participants underwent the same assessment procedures as 
those in the ACT condition, but otherwise had no involvement with the research team beyond the 
typical course of treatment. Treatment at the residential facility is based on a comprehensive system 
designed to normalize eating patterns, stabilize or increase weight, and eliminate compensatory 
behaviors. Patients are assigned to a treatment team consisting of a clinical psychologist, a 
psychiatrist, a master’s level primary therapist, a registered nurse, a dietician, a family therapist, and 
art and movement therapists. The treatment package provides an intensive and comprehensive 
program of individual, group, and family therapy. Psychotherapy groups focus on topics such as 
assertiveness, family patterns, sexuality, symptom management, and relaxation to help participants 
develop insights and enhance their adaptive coping skills. Patients meet with their individual therapist 
two times per week, with therapy focusing on an integration of psychodynamic, interpersonal, and 
cognitive-behavioral strategies.  As part of TAU, patients also attended evening counselor run groups 
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that addressed topics such as leisure planning, coping skills, and female bonding. These groups 
occurred nightly for 60-75 minutes.  
2.3.3.  TAU+ACT 
 Participants in the TAU+ACT (subsequently referred to as ACT) condition received all TAU 
elements described above but received twice weekly ACT group treatment instead of regularly 
programmed groups.  (The counselor-run groups were cancelled these two nights a week for the 
duration of the ACT component.) The total number of hours spent in treatment groups did not differ 
systematically between TAU and ACT. All patients were instructed to attend these ACT groups by 
their individual therapists as a part of their required group schedule. Due to the large number of 
residents who attended the groups, two groups were offered each night. Group attendance was 
determined by diagnostic status, with Anorexia and Anorexia-spectrum patients attending one group 
and Bulimia and Bulimia spectrum patients attending the other group. Although the content of the 
groups were identical, this allowed group therapists to use examples that were more specific to those 
experienced by the majority of those in the group (i.e. using more binge/purge examples in the BN 
group and less in the AN group as not everyone endorsed that type of eating disordered behavior).  
This status was determined by their responses on the intake protocol from the Renfrew Center and 
through the responses to the eating disorder section of the SCID.   
The groups utilized an open format to account for the presence of new admits and discharges 
occurring before and after each group.  Each group contained about 50% overlap from the previous 
session to allow for review of material for returning members and catching up for new group 
members. Eight unique groups were offered. This number was chosen to align with the average 
length of stay (28 days).  Therefore, the average patient was able to attend all eight groups, although 
the order that they attend the groups in varied. Each group covered a variety of core ACT processes 
such as acceptance, willingness, defusion, creative hopelessness, mindfulness, values, committed 
action, and self as context.  In addition to the cognitive skills listed above, a main focus of the groups 
was on identifying, working on, and achieving behavioral goals. Many of these were drawn from the 
behavioral suggestions recommended by conventional CBT for eating disorders such as 
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normalization of eating, reducing dietary restraint, and eliminating compensatory behaviors. 
Additionally, each group contained at least one exposure activity, which was either body/eating 
focused or interpersonally focused.  Although most patients were potentially able to attend all 8 
groups based on their length of stay, many patients missed groups due to a variety of reasons. 
Therefore, attendance at 3 groups was considered a sufficient dosage of treatment to be considered a 
treatment completer.   
2. 4 Statistical Analysis 
1. ACT + TAU will have good treatment acceptability.  
a. To test this hypothesis, the mean scores on the treatment acceptability questionnaire 
(both total scores and individual items) were calculated and reported. Total scores on 
the treatment acceptability measure higher than a mean of 30 indicate high levels of 
treatment acceptability. Acceptability of TAU and TAU+ ACT was compared by 
using an independent measures t-test to examine mean differences in acceptability.  
2. ACT + TAU will result in a larger decrease in disordered eating behavior and body image 
dissatisfaction and larger increases in QOL than TAU at post-treatment and follow-up.  
a. This hypothesis was tested using Hierarchical Linear Modeling (HLM) with pre- 
treatment, post-treatment, and follow-up assessment data. The dependent variables 
were scores on the EDE-Q, EDI-2, GDS, and EDQOL. BMI for both AN and BN 
spectrum patients was also assessed. The main outcome of interest was the interaction 
between time and treatment in predicting outcome variables.  A similar approach was 
used for process variables, but only pre-treatment and post-treatment data were 
utilized.  
3. Eating disorder diagnosis will be a moderating variable at post-treatment and follow-up.  
a. This hypothesis was tested by adding eating disorder diagnosis as a separate 
independent variable into the HLM described above. The main outcome of interest 
was the interaction between diagnosis, time, and treatment in predicting outcome 
scores.  
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4. The effect of ACT+ TAU at post-treatment and follow-up will depend on dosage. 
a. This hypothesis was tested by adding session attendance to a similar HLM as 
described above, but only for those in the ACT group. The main outcome of interest 
was the interaction between session attendance and time in predicting outcome scores.  
5. Changes in core ACT variables such as acceptance, mindfulness, defusion, and values clarity 
will mediate improvement in eating disorder symptoms.  
a. Mediation was tested through the use of bootstrapping. Bootstrapping is a re-
sampling method , wherein a sample of cases are taken from the original sample and 
are used to estimate the indirect effects (Preacher & Hayes, 2008; Shrout & Bolger, 
2002). This process is repeated 1,000 times, such that there ends up being 1,000 
estimates of the total and indirect effects of independent variable on the dependent 
variable.  For the current study, the independent variable was group condition, the 
dependent variables were scores on outcome measures and the mediation variables 
were scores on the ACT process variables and the process items from the BSQ.  
Previous research has demonstrated that bias corrected bootstrap confidence 
intervals provided the most accurate confidence intervals, so these were used in the 
current study (Preacher & Hayes, 2008).  
2.6 Power Analysis 
The effect of greatest interest is that of time by treatment interaction.  A recent meta-analysis 
of ACT demonstrated that ACT has a clear advantage over TAU for other disorders, with an average 
effect size of .42, indicating a medium effect size (Powers, et al., 2009). Because estimating power for 
HLM analyses is complex, power for the current study was calculate for an equivalent RM ANOVA. 
Assuming a medium effect size (.50) and an alpha of 0.05, the study required a minimum of 52 
participants to achieve a power of 0.80 (Cohen, 1992). A total of 140 patients were recruited to allow 
for a sufficient N after attrition.  
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CHAPTER 3: RESULTS 
3.1. Participant Enrollment 
A total of 159 women who met initial inclusion criteria admitted to the Renfrew Center during 
the time period of data collection. Of the 159 who were approached to participate in the study (all of 
whom were eligible after additional screening), 140 consented to take part in the study (TAUa: 20, 
ACT=66, TAUb=54). Twenty women did not return pre-treatment questionnaires (TAUa= 3, ACT= 5, 
TAUb=12) because they were no longer interested in participating (n=18) or because they left the unit 
due to insurance coverage (n=2). Retention was high throughout the initial phase of the study, with 
111 (92.5%) completing post-treatment questionnaire packets (ACT= 58, TAUb=53); see Figure 1 for 
a complete CONSORT flow sheet. A higher proportion of TAUb women failed to return pre-treatment 
(χ² = 5.38, p = .06) and post-treatment (χ² = 7.38, p = .02) questionnaires compared to the other two 
waves, most likely because the research staff in place at that time made less effort to contact patients 
who hadn’t returned packets. To ensure that the two TAU waves appeared equivalent and could be 
combined in all future analyses, a series of one way ANCOVAs were conducted comparing the groups 
on all post-treatment outcome measures when controlling for baseline scores on the measure. Only 
small and statistically insignificant differences were found on any of the measures, suggesting the 
groups showed relatively equal improvements during treatment. Because both TAUa and TAUb 
showed  relatively identical treatment outcomes, these were combined into one group (henceforth 
referred to as TAU) as the use of one comparison group will improve power on all subsequent 
analyses.  
3.2. Baseline Characteristics 
Groups were generally equivalent on demographic characteristics and baseline symptom, 
process and well-being variables (see Table 1). The exceptions were that in the ACT group, EDI-
bulimia and DERS impulsivity were higher and DERS emotion regulation was lower.  Analyses were 
performed both with and without these variables as covariates; because results were virtually identical, 
only the latter analyses are reported.  
3. 3. Treatment Length 
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 The average length of stay was 28.54 days overall (SD= 14.01, range 3-90), 27.34 days 
(SD=10.54) in the ACT group and 29.63 days (SD= 10.93) in the TAU group; t(137) = 0.95; p=.34.   
The average number of ACT groups attended by ACT participants was 4.75 (SD= 2.51, range 0-11). 
Completers (defined as attending 3 or more groups; n=56 of whom 52 completed post-treatment 
measures) were generally equivalent to non-completers on demographic and baseline variables, with 
only length of stay differing between the two groups (Completers: 28.83 days, SD=10.24, Non-
Completers: 19.00, SD=8.36, t(64)=2.86, p<.01).  All analyses described below were conducted with 
ACT group completers only and with the full sample, and results were virtually identical. Therefore, 
only completer analyses (All TAU patients and those in the ACT group who attended 3 or more 
groups) will be reported.     
3.4. Treatment Acceptability 
Overall, across groups, the scores for overall treatment acceptability were high, with all 
individual items averaging over 5 (out of 7) and the total (35.90, SD= 4.93) well over the pre-
established cut-off (30) for an acceptable treatment. Individual and total acceptability items were 
equivalent between groups except the TAU condition reported greater acceptability (t (83) =3.21, 
p<.01; ACT Mean: 5.40 and TAU Mean: 6.28) and effectiveness (t (71.96) =2.02, p=.05; ACT Mean: 
5.65 and TAU Mean: 6.15).  
3.5. Changes across groups  
To facilitate ease of comparison, overall changes during treatment across groups were 
assessed using independent samples t-tests. As can be seen in Table 2, large improvements were 
observed in nearly all outcome variables during the course of treatment.  These outcomes worsened 
between post-treatment and follow-up, but, overall, follow-up scores showed improvement compared 
to pre-treatment.  Process variables also improved from pre- to post-treatment, but, as previously 
described, were not sufficiently collected at follow-up to report.  As would be expected, between post- 
and follow-up, nearly all (95.3%) participants reported additional treatment, specifically day treatment 
(32.8%), intensive outpatient (14.1%), a combination of day and intensive outpatient (25%), additional 
inpatient or residential treatment (12.5%), or outpatient treatment (10.9%). 
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3.6. Main outcome analyses: Process variables between groups.  
Because only two data points were available, outcome analyses were performed using a linear 
HLM. The best fitting model for all outcome variables appeared to be a random intercept model, 
suggesting the data was too sparse to model a more complex equation.  With one exception, there were 
no significant differences in improvements across conditions, with both those conditions showing 
large improvements. Only the VLQ importance subscale trended towards significance, with those in 
the ACT group showing greater increases in values clarity. See Table 3 for the means at post-treatment 
and Table 4 for the interaction term results- full tables for this and all other HLM analyses are 
available upon request. 
3.7. Main outcome analyses: Outcome variables between groups.  
 In order to determine the best fit of the data, a series of models were assessed; Restricted log-
likelihood scores revealed the piecewise models (i.e. a linear change from pre to post which then 
changes slopes at the post-treatment period to make another linear change from post to follow-up) best 
fit the data for all main outcome analyses. Again, the most parsimonious model for all outcome 
variables appeared to be a random intercept model.  Several trends were also observed for EDE scores 
at post-treatment, with those in the ACT condition showing faster and larger decreases in weight 
concern (p=.07), shape concern (p=.09), and global eating pathology (p=.09) at post-treatment. Other 
EDE variables followed a similar pattern, but did not reach the trend level. The time by treatment 
interaction indicated that individuals in the TAU condition also experienced more rapid worsening in 
bulimic symptoms from post-treatment to 6-month follow-up (p=.02), despite no significant 
differences in these symptoms by post-treatment. See Table 3 for the means of all outcome variables, 
Table 5 for the results of the HLM analyses, and Figure 2 for a graphical representation of selected 
results. The EDQOL data (which was analyzed separately as only pre-treatment and follow-up data 
were available) revealed no significant differences between conditions, but the work/school subscale 
showed a trend towards significantly greater improvements in the ACT group (t(81.92)=1.85, p=.06, 
ACT: M= .62, SE= .18; TAU: M=1.03, SE=.17). 
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Additional treatment between post-treatment and follow-up was also assessed as an outcome 
variable in two ways. First, the variable was dichotomized into those who did or did not return to 
inpatient care.  Those in the TAU group were more likely to be re-hospitalized (18%) compared to the 
ACT group (3.5%; χ²=3.19, p=.07).  Second, the variable was trichotomized to reflect those who were 
re-hospitalized, those who received stepped down care (i.e., day treatment, intensive outpatient, 
outpatient, all of which are part of discharge planning) or those who received no treatment (which was 
contrary to discharge plan). These results suggested that those in the TAU condition were more likely 
to be re-hospitalized and to receive no treatment, and were less likely to receive stepped-down care, 
(χ²=4.94, p=.08), suggesting overall worse treatment seeking behavior from post-treatment to follow-
up in this group.   
3.8. Clinical Significance 
Clinical significance was assessed by examining the rates of EDE global score within 1 
standard deviation of the community mean (EDE global below 1.74; Murphy, Straebler, Cooper, & 
Fairburn, 2010). Normative comparisons of this type are widely used to identify clinically significant 
change (Kendall, Marrs-Garcia, Narth, & Sheldrick, 1999; Ogles, Lunnen, Bonesteel, 2001; Kazdin, 
2003).  At pre-treatment, seven individuals (4 in TAU and 3 in ACT) were already within the 
normative range and were therefore excluded from these analyses. A larger portion of ACT individuals 
scored within one standard deviation of normative EDE-Global scores by post-treatment (ACT: 33%; 
TAU: 17%; χ²= 5.56, p=.02), but this was no longer the case at follow-up (ACT: 3%; TAU: 13%; χ²= 
1.64, p=.19).  
3.9. Moderation Analyses  
A series of HLM analyses were conducted to assess potential moderating variables. 
3.9.1 Eating Disorder Diagnostic Status.   
Results indicate that AN spectrum patients show higher restrictive eating overall and have 
greater increases in restrictive eating between post-treatment and follow-up. BN spectrum patients 
have higher bulimic symptoms and show greater increases in bulimic symptoms between post-
treatment and follow-up.  The 3-way interaction between time, treatment condition, and spectrum 
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diagnosis was not significant for most variables, though two trends were observed: AN spectrum 
patients experienced greater reductions in restraint from pre- to post-treatment in the ACT condition 
and BN spectrum patients had greater reductions in the TAU condition (Table 6; Figure 3). 
3.9.2 Session Attendance.  
 Analyses also revealed that higher session attendance (which was strongly associated with 
length of stay, r = .64, p < .01) was associated with greater improvements in EDE-Q Weight, Shape, 
and Global subscale scores from pre-post treatment (Table 7).    
3.9.3. Baseline Process Variables.  
 In addition, nearly all process variables were significant moderators of the relationship 
between treatment condition and time in predicting outcome variables, with more rapid improvement 
occurring in those who began treatment at lower levels of process variables (e.g., less mindful; Table 
8). Those with lower scores on process variables did best in the ACT condition.  
3.10. Mediation Analyses  
Mediation analyses were conducted using two types of measures: the standard process 
measures given at pre-treatment, post-treatment, and follow-up and the Brief Symptom Measure 
(BSQ) given one time each week. Preacher & Hayes bootstrapping method (Preacher & Hayes, 
2008) was used as an initial test of mediation, with change from pre to mid treatment on the mediator 
variables predicting changes from pre-post on the outcome variables. Most tests did not support 
mediation hypotheses.  However, BSQ-General Willingness  significantly mediated  EDE eating 
concern (CI= -.4841 to - .0138), EDE weight concern (CI= -.5003 to -.0021), and EDE shape concern 
(CI: -.4985, to -.0028), and BSQ-Food Specific Willingness mediated EDI body dissatisfaction (CI= 
.0043 to 2.5272). Lack of significance  for other potential mediators appeared to be primarily due to 
poor relationships between the mediator variables and the dependent variables, as condition was 
significantly associated with many mediator variables in the hypothesized directions.  
.   
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CHAPTER 4: DISCUSSION 
4.1. Current Study 
 Prior research has indicated that eating disorders are exceptionally difficult to treat (Fairburn, 
2008). Even state-of-the-art treatment by highly trained therapists leave a large portion of bulimic 
patients either partially or fully symptomatic (Wilson, 2005) and the outcomes for anorexia are even 
worse (Wilson et al., 2007). It has been theorized that the lack of efficacy of predominant treatment 
models stems from their failure to focus on important maintance factors such as experiential 
avoidance/distress intolerance (Anestis et al., 2007, Corstorphine et al., 2006, Cockell et al., 2002; 
Keyser et al., 2009; Mizes & Arbitell, 1991; Orsillo &Batten, 2002), alexithymia/emotional 
unawareness (Harrison et al., 2009; Zonnevylle-Bender et al., 2004; Zucker et al., 2007), and lack of 
values clarity (Serpell et al., 1999, Merwin & Wilson, 2009).  Third generation CBT treatments such 
as Acceptance and Commitment Therapy do target these potential maintanence factors (Hayes et al., 
2004), but only limited empirical research has been conducted examining ACT as a potential 
treatment for eating disorders. The current study sought to examine the incremental efficacy of an 
ACT treatment group when added to a pre-existing program at a residential treatment facility.  
4.2. Treatment Acceptability 
 Overall, patients appeared to find the addition of the ACT groups to the residential treatment 
program highly acceptable. Interestingly, individuals in the TAU condition were more likely to 
believe that treatment was acceptable and effective. Given that patients were rating their overall 
treatment experience (i.e., patients in the ACT condition were rating their overall inpatient treatment 
experience), this result could have two meanings: something about the combined treatment or the 
ACT group was less acceptable (e.g., the anxiety-provoking experiential exercises) or the overall 
treatment appeared less valuable for those who had ACT groups as a standard of comparison.  We 
favor the latter interpretation because those patients reported more gains in outcomes and because so 
many patients spontaneously reported postitive group experiences (going as far as to lobby the 
agency’s administration to make the ACT groups a permanent part of standard treatment). As the 
ACT group was very different from the other types of groups being offered (all non-manulized, 
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process oriented groups without exposure activities), the ACT groups were likely percieved as a 
novel component of treatment. Although contradictory to hypotheses, these results do offer some 
further support that the ACT condition is not showing additional improvement solely as an artificat 
of patients “liking” the ACT treatment condiction better or wanting to please the researchers. 
Additional research and more focused questionnaires could help ensure that ACT groups are an 
acceptable treatment for an eating disorder population.  
4.3. Main Outcomes 
 The main hypotheses for the current study were partially supported. Individuals in the ACT 
condition trended towards lower global eating pathology, shape concerns, and weight concerns by 
post treatment and had significantly less bulimic pathology by six-month follow-up. Perhaps even 
more significant, a lower proportion of ACT group participants required rehospitalization.  Although 
results at post-treatment are only trends and the effect size is relatively small, it is remarkable that the 
addition of the twice-weekly ACT group improved outcomes over and above the effect of a much 
larger and more widescale treatment program (i.e., TAU), especially considering this treatment 
results in considerable improvement on its own.  The fact that patients in the ACT condition showed 
fewer bulimic symptoms at follow-up suggests that the effects of an ACT treatment are long-lasting. 
With few treatments for eating disorders producing long term reductions in eating pathology, the 
reductions in bulimic symptoms for ACT patients suggests that this is a treatment worth investigating 
further. If participation in a handful of ACT groups can lead to long-term reductions in eating 
pathology above and beyond the effects of a full residential treatment program, it seems important to 
examine what a full course of ACT treatment, such as a residential program that was primarily ACT 
based, or an ACT based outpatient treatment might produce. The data here suggest that the skills 
learned in an ACT based treatment such as acceptance of distressing internal experiences and 
willingness to engage in challenging behaviors that are consistent with values can reduce eating 
pathology. Given that eating disorders are such a difficult population to treat, a new treatment that is 
showing additive benefits should certainly be investigated further. Additional research, including 
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longer follow-ups, would allow for a greater understanding of the long-term impacts of an ACT 
based treatment protocol.  
4.4. Moderation Analyses 
 To obtain a greater understanding of who might have most benefited from an ACT based 
treatment, a series of moderation analyses were conducted. It was initially hypothesized that there 
might be differences in treatment success across diagnoses, with AN patients either doing less well 
because it is a more difficult disorder to treat or doing better because ACT targets many of the 
maintainence factors specific to AN. However, diagnostic status does not appear to be a significant 
moderator of treatment effects for most variables, with both AN and BN spectrum patients 
performing similarly in treatment. The moderating effects of restraint scores do suggest that AN 
patient in particular might show some incremental benefit from an ACT treatment. These results may 
be due to ACT’s focus on treating experiential avoidance and values clarity, which tend to be more 
pervasive amongst individuals with anorexia (Hayes & Pankey, 2002; Merwin & Wilson, 2009; 
Schmidt & Treasure, 2006). If replicated, this would be a noteworthy finding as AN spectrum 
patients are typically more challenging to treat and have a worse prognosis. Although restraint was 
the only variable trending towards significance, other variables showed similar patterns suggesting 
that the advantage of the ACT treatment was considerably more evident for AN patients. If these 
results are valid and reproduceable, it would suggest that AN patients require more targeted 
interventions to address their specific maintanence factors such as experiential avoidance, low 
distress tolerance, and poor values clarity. Many BN patients may require only the behavioral 
interventions inherent in a residential facility such as normalization of eating behavior to achieve 
good results. Although only trends, the differences across diagnostic status should be examined more 
closely in future studies powered to assess for moderating variables.  
 As was expected, greater session attendance was found to enhance the impact of the ACT 
condition.  However, interpreting this result is complicated by the fact that attendance is confounded 
with length of stay (and thus with severity and treatment response). A test of a model controlling for 
length of stay was conducted, but the results were inconclusive because of low power. Additional 
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research both with larger samples and amongst patient populations where length of stay will not be a 
confounding variable (i.e. in a trial where everyone recieves the same number of ACT sessions) can 
better clarify the influence of receiving more or less ACT treatment.  
 Prior research has suggested that individuals who are higher in certain ACT related variables 
such as acceptance or mindfulness (Herbet et al., 2010) tend to show greater benefits from an ACT 
based treatment. The results of our sample were contary to this trend, with those lower in ACT 
process variables tending to have the best response to the ACT treatment. These findings suggest that 
an ACT-based treatment is best suited for individuals who are low on ACT related variables, perhaps 
because treatment can then target and improve on these constructs.  
4.5. Mediation analyses 
 Formal tests of mediation suggested that willingness to experience negative thoughts or 
emotions while still engaging in valued behaviors was a significant mediator of global eating 
pathology, eating concern, weight concern, and body image dissatisfaction. Individuals in the ACT 
group showed bigger improvements in these items, which then predicted greater reductions in 
symptoms. It appears that willingness, as opposed to other ACT related variables such as acceptance, 
mindfulness, values clarity,  and defusion, was most strongly associated with the improvements seen 
in the ACT condition. Since both ACT and TAU showed significant increases in most process 
variables, it suggests that TAU is teaching patients how to step back from their thoughts, sit with 
distressing internal experiences, and achieve better clarity regarding non- eating disorder values. 
However, the skill of engaging in values-consistent behavior when experiening distressing internal 
experiences may not be as well taught, and an ACT based approach may be needed to help patients 
learn to be more willing.    
4.6. Limitations 
 Despite the positive findings of the current study, a  number of limitations exist. First, the 
study was designed as a pilot study, and the use of a residential treatment program as a comparison 
group (where it was only possible to add in a small number of ACT groups) was likely not the ideal 
control group but rather was chosen because it allowed researchers to target a suitable number of 
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patients.  Ideally, ACT should be tested as a stand-alone treatment in a variety of settings  and against 
more stringent control conditions (such as empirically-supported treatments like CBT for eating 
disorders). These conditions would allow for greater certainty that ACT can achieve significant 
improvements in eating pathology with out the support of a pre-existing residential treatment. 
Additionally, given the large changes observed during the course of TAU, there may have been little 
room for incremental effects of the ACT program. This fact combined with the relatively low dose of 
ACT treatments may have under-estimated the effects of ACT as a potential treatment.  
 Other limitations included the limited prior research involvement at the residential facility. 
As the setting is almost entirely clinically focused, the amount of support given to research is low, 
and the completion of research activities is often given a lower priority than is ideal for a treatment 
outcome study. Patients were often cut by insurance prematurely and discharged before members of 
the research team were availabile to complete a post-treatment assessment. These discharges could 
have biased results, particularly as a greater number of missed discharges occurred during the second 
TAU period due to changes in research staffing. Although the study attempted to mitigate these 
limitations by checking for equivalency between completers and drop-outs and the use of intention to 
treat analyses, additional research in a more well controlled setting with higher research support 
would allow for greater confidence in these results.  
 While the study was sufficiently powered for the main outcome analyses, moderation and 
mediation analyses were often underpowered.  Although this is typical in treatment outcome 
research, the ability to interpret mediation and moderation results are limited, some effects may have 
been missed.  Future research using large samples could allow for more accurate tests of potential 
mediating and moderating variables. The study also utilized a large number of comparisons, which 
might have elevated the risk of Type 1 error. As this was a pilot study designed to be exploratory in 
nature, we did not control for this elevated rate, but additional research that is better powered would 
benefit from using more stringent alpha levels if numerous tests are conducted. Other limitations 
included the lack of a questionnaire specific to the acceptability and comprehension of the ACT 
groups. These measures could have provided useful information to suggest whether the ACT groups 
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individually were percieved as useful to the patients. Lastly, the use of primarily self-report measures 
to assess constructs such as willingness or distress tolerance is not ideal, and the study would have 
benefited from more objective assessments such as behavioral tasks of distress tolerance or blind 
raters. However, some objective data such as rates of re-hospitalization were consistent with self-
report measures, indicating that the self-report data is valid.  
4.7. Strengths 
 Despite the limitations acknowledged above, these concerns are partially countered by a 
number of strengths. First, this study reflects one of the only tests of the efficacy of an ACT-based 
intevention for an eating disorder population, despite significant research suggesting that ACT would 
be a useful treatment. The use of a full clinical sample, as opposed to subthreshold eating pathology 
or a college undergrad population is also a strength given that this was a pilot study. Although 
underpowered for several analyses, the study reflects a relatively large sample size for eating disorder 
research, making this somewhat well powered for a pilot study in this area. The use of a 6-month 
follow-up allowed for a test of the sustanability of ACT improvements, and is a relatively long 
follow-up for early stage treatment research. Lastly, the use of a control group for pilot research is a 
large strength of the study and allows for more confidence in the intrepreation of results.  
4.8. Conclusions and Future Research 
 The current study is one of the first empirical tests of an ACT-based treatment for eating 
disorders.  Results of this pilot study demonstrate that ACT could be a useful treatment. Ideally, 
additional research would not only replicate the current findings, but extend this research by 
examining other potential uses of ACT based skills, techniques, and treatment programs for eating 
disorder populations. Future studies could examine ACT as a stand alone individual treatment, as an 
adjuntive group treatment, or as a more comprehensive and extensive program in various higher 
levels of care. Although the study begins to hint at the mechanisms of actions for an ACT-based 
treatment, much more research is needed in this area to better understand why this treatment might be 
effective. Larger studies with more assessment periods might provide stronger and more valid tests of 
mediation, which could enhance knowledge about which maintanence factors most need to be altered 
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to ensure treatment success. The use of more objective measures and behavioral assessments would 
also be useful, both as outcome and process measures in ensuring that assessments are not biased by 
self-report.  Lastly, a better understanding of who might benefit from an ACT based treatment would 
allow clinicians to know which patients should focus not only on the behavioral components of 
treatment known to be helpful, but also on these more advanced acceptance based techniques. 
Additional research on moderating variables would likely provide useful information.  
Overall, this pilot study indicates that ACT may be a useful treatment for eating disorders. 
As many researchers have noted, ACT appears to be a  good conceptual fit for this population, but 
the lack of systematic research has limited its use. The benefits of an ACT-based treatment observed 
in this study will hopefully spur additional research on this treatment approach. 
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Table 1: Baseline Characteristics of Sample 
 TAU ACT Group difference 
Variable Mean SD Mean SD t p 
Outcome Measures       
EDE-Q Restraint 3.96 1.65 4.11 1.88 -0.47 .63 
EDE-Q Eating Concerns 3.80 1.32 3.83 1.38 -0.13 .89 
EDE-Q Shape Concerns 4.80 1.47 4.89 1.30 -0.36 .71 
EDE-Q Weight Concerns 4.39 1.64 4.48 1.58 -0.32 .74 
EDE-Q Global Scores 4.28 1.31 4.33 1.27 -0.19 .84 
EDI Drive for Thinness 19.81 7.09 21.26 7.04 -1.12 .26 
EDI Bulimia** 12.93 9.12 18.42 11.45 -2.92 .01 
EDI Body dissatisfaction 26.80 9.87 28.16 10.48 -0.73 .46 
Quality of Life       
Goldberg Sum 47.89 20.53 50.94 18.29 -.82 .40 
EDQOL Psychological 4.97 10.87 2.88 0.80 1.39 .16 
EDQOL Phys/Cog 2.36 0.80 2.32 1.00 0.23 .81 
EDQOL Financial 1.03 1.00 1.33 1.15 -1.50 .13 
EDQOL Work/School 1.37 1.02 1.41 1.02 -0.24 .81 
EDQOL Sum 1.87 0.59 1.99 0.74 -0.89 .37 
Baseline Characteristics       
BMI AN 17.44 2.41 17.17 2.08 0.47 .63 
BMI BN 24.54 8.10 28.32 11.32 -1.65 .10 
Age 25.86 8.20 27.68 10.12 -1.03 .30 
Age of Onset 15.78 4.60 17.11 6.41 -1.34 .21 
Previous Hospitalizations 1.01 2.06 1.34 2.30 -0.81 .42 
Process Variables       
PHLMS total 58.91 9.28 56.82 8.73 1.26 .21 
PHLMS awareness 35.20 6.14 33.85 6.26 1.19 .23 
PHLMS acceptance 23.56 6.62 22.97 7.46 0.46 .64 
DERS acceptance 18.78 7.02 20.02 6.67 -0.99 .32 
DERS goals 17.77 4.73 19.12 4.96 -1.52 .12 
DERS impulsivity* 17.63 6.05 20.15 6.14 -2.27 .02 
DERS awareness 19.09 5.93 19.35 5.76 -0.24 .81 
DERS strategy* 25.71 8.11 28.50 7.12 -1.98 .05 
DERS clarity 15.41 5.27 16.16 4.64 -0.81 .41 
DDS total 24.72 10.85 21.64 9.71 1.62 .11 
EATDS frequency 39.25 18.76 42.48 15.22 -1.02 .31 
EATDS defusion 3.83 4.39 3.16 3.2 0.97 .32 
AAQ-II 24.84 9.88 22.32 10.74 1.41 .16 
VLQ importance 67.28 19.14 59.82 17.34 1.61 .11 
VLQ action 41.67 32.23 35.20 13.11 1.42 .16 
VLQ satisfied action 44.95 24.00 42.52 21.89 0.39 .69 
VLQ valued living 265.72 199.30 240.17 154.83 0.53 .59 
ᵻ Trending towards Significance at p<.01, * Significant at p<.05, ** Significant at p<.01
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Table 2: Paired Sample t-test for overall changes during treatment 
 Pre-treatment Post-treatment Pre-
post 
Pre-
post 
Effect 
Size 
Follow-up Post-
F/U 
Post-
F/U 
Effect 
Size 
Pre-
F/U 
Pre-
F/U 
Effect 
Size 
Variable Mean SD Mean SD t p d Mean SD t p d t p d 
Outcome Measures                
EDE-Q Restraint 4.06 1.75 1.37 1.22 13.83 <.01 1.78 3.26 1.78 7.60 <.01 -1.24 -3.43 <.01 0.45 
EDE-Q Eating Concerns 3.89 1.32 1.99 1.23 13.57 <.01 1.49 3.27 1.70 5.95 <.01 -0.86 -2.46 .02 0.41 
EDE-Q Shape Concerns 4.93 1.29 3.74 1.68 8.14 <.01 0.10 4.40 1.46 2.10 .04 -0.42 -2.11 .04 1.18 
EDE-Q Weight Concerns 4.56 1.50 3.38 1.71 7.90 <.01 0.73 4.02 1.62 2.57 .01 -0.38 -1.65 .10 0.35 
EDE-Q Global Scores 4.39 1.23 2.62 1.32 13.98 <.01 1.39 3.74 1.50 5.37 <.01 -0.79 -2.74 <.01 0.47 
EDI Drive for Thinness 20.80 6.91 17.18 7.97 4.44 <.01 0.49 15.45 5.59 -1.15 .25 0.25 -5.16 <.01 0.85 
EDI Bulimia 15.74 10.44 8.47 10.32 7.24 <.01 0.70 17.23 9.22 9.91 <.01 -0.90 -3.93 <.01 -0.15 
EDI Body dissatisfaction 27.98 9.89 26.51 9.78 1.74 .08 0.15 22.20 4.68 -3.23 <.01 0.56 -3.89 <.01 0.75 
BMI BN 26.16 9.42 26.24 9.95 0.46 .44 -0.01 25.74 2.15 0.22 .82 0.07 0.41 .68 0.06 
BMI AN 17.32 2.23 18.83 2.23 9.18 <.01 -0.68 19.04 2.50 1.37 .17 -0.09 5.06 <.01 -0.73 
Quality of Life                
Goldberg Sum 50.05 18.49 31.21 17.40 8.32 <.01 1.05 41.73 22.54 3.29 <.01 -0.52 -2.83 <.01 0.40 
EDQOL psych 2.89 .74     -2.30 2.51 .94   2.33 -2.67 <.01 0.01 
EDQOL physcog 2.33 .91     -2.34 1.76 1.08   2.39 -3.93 <.01 0.57 
EDQOL finance 1.03 .91     -2.45 1.05 1.07   2.45 1.61 .87 -0.02 
EDQOL work 1.20 .94     -2.44 .83 1.05   2.38 -2.47 .02 0.37 
EDQOl Sum 1.86 .67     -2.38 1.54 .86   2.41 -2.77 <.01 0.42 
ACT Related Variables                
PHLMS total 57.98 9.20 60.81 10.26 3.00 <.01 -0.29         
PHLMS awareness 34.32 6.35 35.08 7.16 1.23 .22 -0.11         
PHLMS acceptance 23.69 6.57 25.84 6.45 2.91 <.01 -0.32         
DERS acceptance 19.32 6.46 16.99 6.28 -3.85 <.01 0.35         
DERS goals 18.63 4.86 16.69 4.77 -3.81 <.01 0.40         
DERS impulsivity 18.45 6.14 15.70 5.88 -4.68 <.01 0.46         
DERS awareness 19.43 5.61 16.76 5.73 -3.90 <.01 -0.74         
DERS strategy 27.39 7.59 23.65 8.07 -5.04 <.01 0.48         
DERS clarity 15.86 5.18 13.62 4.31 -4.08 <.01 0.47         
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DDS total 22.76 9.25 32.39 9.96 5.91 <.01 -1.00         
EATDS frequency 40.71 16.55 47.35 14.18 3.60 <.01 -0.43         
EATDS defusion 3.32` 3.53 8.02 5.10 8.01 <.01 -1.07         
AAQ-II 23.20 10.31 26.54 10.10 -3.56 <.01 -0.42         
VLQ importance 62.73 19.16 65.56 17.12 -1.70 .09 -0.16         
VLQ action 37.95 17.31 46.09 19.58 -3.75 <.01 0.90         
VLQ satisfied action 48.57 24.22 57.51 26.82 -1.77 .08 -0.35         
VLQ valued living 271.14 194.39 332.53 209.71 -1.86 .07 -0.30         
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Table 3: Means for ACT and TAU at Post-treatment and Follow-up  
 
 Post TAU Post ACT Follow-up 
TAU 
Follow-up 
ACT 
Variable Mean SD Mean SD Mean SD Mean SD 
Outcome Measures         
EDE-Q Restraint 1.53 1.38 1.22 1.07 3.43 1.91 3.19 1.64 
EDE-Q Eating Concerns 2.20 1.24 1.80 1.19 3.27 1.90 3.38 1.49 
EDE-Q Shape Concerns 3.99 1.48 3.50 1.83 4.50 1.40 4.34 1.52 
EDE-Q Weight Concerns 3.66 1.64 3.12 1.79 4.13 1.69 3.93 1.57 
EDE-Q Global Scores 2.85 1.30 2.41 1.32 3.83 1.59 3.71 1.43 
EDI Drive for Thinness 17.26 7.20 17.10 8.62 14.35 6.57 17.06 4.09 
EDI Bulimia 6.41 8.73 10.11 11.23 19.06 8.77 16.58 10.93 
EDI Body dissatisfaction 27.33 8.78 25.40 10.96 22.88 5.37 22.55 5.97 
BMI AN 19.09 2.62 18.53 1.62 19.30 2.39 18.80 2.64 
BMI BN 24.52 7.80 28.06 10.69 23.24 10.69 29.15 15.60 
Quality of Life         
Goldberg Sum 47.89 20.53 50.94 18.29 41.61 22.73 40.18 22.22 
EDQOL Psychological     2.47 .91 2.50 1.00 
EDQOL Physical/Cognitive     1.74 1.12 1.73 1.12 
EDQOL Financial     1.04 .99 1.05 1.14 
EDQOL Work/School     .98 1.19 .62 .84 
EDQOL Sum     1.56 .88 1.48 .85 
Process Variables         
PHLMS total 62.11 10.36 60.20 10.29     
PHLMS awareness 36.16 6.77 34.52 7.59     
PHLMS acceptance 26.14 6.03 25.68 7.14     
DERS acceptance 16.14 6.60 17.46 5.87     
DERS goals 16.24 4.67 16.73 5.14     
DERS impulsivity 14.31 5.68 16.67 5.87     
DERS awareness 17.14 5.86 15.78 5.70     
DERS strategy 22.85 8.23 24.01 8.10     
DERS clarity 13.63 4.45 13.34 4.22     
DDS total 31.84 9.80 32.73 4.22     
EATDS frequency 44.98 14.58 50.57 12.66     
EATDS defusion 8.51 5.19 7.48 4.98     
AAQ-II 26.86 10.91 26.25 9.37     
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Table 4: HLM for ACT variables 
 
 
Variable Parameter Coefficient SE df t p 
PHLMS total Treatment by Time .66 1.84 102.69 .36 .72 
PHLMS awareness Treatment by Time .73 1.20 103.75 .61 .54 
PHLMS acceptance Treatment by Time .10 1.47 97.16 .07 .94 
DERS non-accept Treatment by Time -1.11 1.19 97.17 -.93 .35 
DERS goals Treatment by Time -.18 .99 103.93 -.18 .85 
DERS impulse Treatment by Time -.82 1.15 101.31 -.71 .47 
DERS aware Treatment by Time .967 1.34 102.93 .72 .47 
DERS strategy Treatment by Time .213 1.46 100.72 .15 .88 
DERS clarity Treatment by Time .63 1.05 107.59 .60 .54 
DDS total Treatment by Time -4.11 2.81 211.00 -1.46 .14 
EATDS freq Treatment by Time -2.90 3.61 95.85 -.80 .42 
EATDS defuse Treatment by Time 0.46 1.17 113.84 .40 .68 
AAQ Treatment by Time -1.24 2.11 48.25 -.53 .54 
VLQ importance Treatment by Time -5.67 3.21 49.55 -1.76 .08 
VLQ action Treatment by Time 0.76 4.03 58.47 0.18 .85 
VLQ satisfied action Treatment by Time 5.77 7.71 80.91 0.74 .45 
VLQ composite Treatment by Time 54.43 54.59 70.51 .99 .32 
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Table 5: HLM for Main Outcome Analyses 
Variable Parameter Coefficient SE df t P 
EDE-Q Restraint Tx* Leg 1 -.52 .33 174.22 -1.36 .17 
 Tx* Leg 2 .045 .46 198.61 .098 .92 
EDE-Q Eating Concern Tx* Leg 1 -0.392 .30 179.75 -1.30 .19 
 Tx* Leg 2 .418 .370 199.93 1.13 .26 
EDE-Q Shape Concern Tx* Leg 1 -.50 .30 173.23 -1.67 .09ᵻ  
 Tx* Leg 2 .06 .37 188.73 .179 .85 
EDE-Q Weight Concern Tx* Leg 1 -.61 .33 165.25 -1.82 .07ᵻ  
 Tx* Leg 2 .12 .41 180.14 .299 .76 
EDE-Q Global Tx* Leg 1 -.48 .29 166.68 -1.66 .09ᵻ  
 Tx* Leg 2 .13 .35 183.87 .36 .56 
EDI Drive for Thinness Tx* Leg 1 -1.46 1.70 162.18 -.86 .39 
 Tx* Leg 2 2.46 2.09 188.30 1.17 .24 
EDI Bulimia Tx* Leg 1 -1.34 1.96 158.43 -.68 .49 
 Tx* Leg 2 -5.66 2.44 172.65 -2.32 .02* 
EDI Body Dissatisfaction Tx* Leg 1 -2.71 1.89 153.42 -1.44 .15 
 Tx* Leg 2 .18 2.34 169.72 .08 .94 
Goldsum Tx* Leg 1 -2.43 4.63 157.28 -.52 .60 
 Tx* Leg 2 -1.42 5.41 168.56 -.26 .79 
BMI AN Tx* Leg 1 .27 .47 94.78 .58 .56 
 Tx* Leg 2 .65 .58 99.01 1.12 .26 
BMI BN Tx* Leg 1 .06 .64 86.91 .10 .92 
 Tx* Leg 2 .97 .97 87.65 1.01 .31 
ᵻ Trending towards Significance at p<.01, * Significant at p<.05, ** Significant at p<.01 
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Table 6: Diagnostic Status Moderation Analyses.  
 
Variable Parameter Coefficient SE df t P 
EDE-Q Restraint Tx*Diagnosis*Leg1 -2.06 1.10 232.36 -1.87 .06ᵻ  
 TX*Diagnosis*Leg2 .70 .94 195.93 .75 .45 
EDE-Q Eating Concerns Tx*Diagnosis*Leg1 -1.03 .93 238.99 -1.10 .27 
 Tx*Diagnosis*Leg2 .44 .78 185.75 .59 .57 
EDE-Q Shape Concerns Tx*Diagnosis*Leg1 -.51 .97 258.73 -.52 .60 
 Tx*Diagnosis*Leg2 .20 .79 174.86 .26 .79 
EDE-Q Weight 
Concerns 
Tx*Diagnosis*Leg1 -1.32 1.04 251.12 -1.27 .20 
 Tx*Diagnosis*Leg2 .77 .84 175.03 .917 .36 
EDE-Q Global Tx*Diagnosis*Leg1 -1.28 .88 244.83 -1.46 .14 
 Tx*Diagnosis*Leg2 .58 .72 178.33 .81 .41 
EDI Drive for Thinness Tx*Diagnosis*Leg1 .92 5.08 229.27 .18 .85 
 Tx*Diagnosis*Leg2 -3.68 4.30 183.26 -.86 .39 
EDI Bulimia Tx*Diagnosis*Leg1 -6.42 6.04 246.73 -1.06 .28 
 Tx*Diagnosis*Leg2 2.77 4.88 170.73 .568 .57 
EDI Body 
Dissatisfaction 
Tx*Diagnosis*Leg1 -4.67 5.99 244.44 -.78 .43 
 Tx*Diagnosis*Leg2 1.13 4.83 154.19 .233 .81 
Goldsum Tx*Diagnosis*Leg1 -13.21 13.23 218.67 -1.00 .31 
 Tx*Diagnosis*Leg2 15.27 10.87 162.93 1.40 .16 
BMI Tx*Diagnosis*Leg1 2.64 2.49 196.64 1.06 .29 
 Tx*Diagnosis*Leg2 .17 1.10 183.27 .16 .87 
ᵻ Trending towards Significance at p<.01, * Significant at p<.05, ** Significant at p<.01 
 
 
 
 
 48 
Table 7: HLM for Session Attendance 
 
 
Variable Parameter Coefficient SE df t P 
EDE-Q Restraint Attendance* Leg 1 .06 .11 92.42 .59 .55 
 Attendance* Leg 2 -.16 .14 107.00 -1.15 .25 
EDE-Q Eating Concern Attendance* Leg 1 .10 .08 90.68 1.13 .26 
 Attendance* Leg 2 -.02 .11 102.190 -.21 .83 
EDE-Q Shape Concern Attendance* Leg 1 .23 .09 87.62 2.42 .01 
 Attendance* Leg 2 -.11 .12 97.54 -.90 .37 
EDE-Q Weight Concern Attendance* Leg 1 .25 .10 87.96 2.55 .01 
 Attendance* Leg 2 -.07 .12 97.08 -.57 .57 
EDE-Q Global Attendance* Leg 1 .16 .08 90.24 1.95 .05 
 Attendance* Leg 2 -.09 .10 100.54 -.84 .40 
EDI Drive for Thinness Attendance* Leg 1 .01 .43 86.42 .01 .98 
 Attendance* Leg 2 -.03 .56 96.10 -.06 .95 
EDI Bulimia Attendance* Leg 1 -.54 .56 85.49 -.96 .33 
 Attendance* Leg 2 .06 .74 93.57 .08 .93 
EDI Body Dissatisfaction Attendance* Leg 1 .17 .55 83.89 .30 .76 
 Attendance* Leg 2 -1.18 .72 93.74 -1.65 .10 
Goldberg sum Attendance* Leg 1 .00 1.45 76.14 .01 .99 
 Attendance* Leg 2 -.83 1.64 78.82 -.51 .61 
BMI AN Attendance* Leg 1 -.01 .01 94.77 -.58 .56 
 Attendance* Leg 2 -.01 .01 99.01 -1.12 .26 
BMI BN Attendance* Leg 1 -.06 .01 86.91 -.10 .92 
 Attendance* Leg 2 -.09 .01 87.65 -1.01 .31 
 49 
Table 8: HLM for Baseline Variables predicting outcome.  
PHLMS 
Total 
Variable Parameter Coefficient SE df t p 
 EDE-Shape  Tx*Leg1*PHLMS total .06 .04 150.52 1.71 .08 
 EDI Bulimia Tx*Leg1*PHLMS total .58 .22 145.02 2.61 .01 
  Tx*Leg2*PHLMS total -.42 .25 .15241 -1.65 .10 
 EDI BD Tx*Leg1*PHLMS total .43 .22 141.30 1.99 .04 
 Goldberg Sum Tx*Leg1*PHLMS total .83 .50 142.31 1.66 .10 
  Tx*Leg2*PHLMS total -1.06 .56 151.75 -1.89 .06 
PHLMS 
Acceptance 
EDE-Shape  Tx*Leg1*PHLMS acceptance .13 .05 154.91 2.56 .01 
 EDE-Weight  Tx*Leg1*PHLMS acceptance .12 .06 156.49 2.16 .03 
 EDE-Global  Tx*Leg1*PHLMS acceptance .09 .05 157.84 1.94 .05 
 EDI-DT Tx*Leg1*PHLMS acceptance .51 .28 153.17 .1.79 .07 
 EDI-Bulimia  Tx*Leg1*PHLMS acceptance 1.19 .32 149.41 3.74 <.01 
  Tx*Leg2*PHLMS acceptance -.88 .39 159.75 -2.23 .02 
 EDI-BD Tx*Leg1*PHLMS acceptance .43 .22 141.30 1.99 .04 
PHLMS 
Aware 
EDI-DT Tx*Leg2*PHLMS  aware .61 .30 169.72 2.01 .04 
DERS 
Non-accept 
EDI-Bulimia  Tx*Leg2* DERS non accept .81 .38 162.00 2.14 .03 
DERS 
Goals 
EDI-Bulimia  Tx*Leg1* DERS goals -.90 .41 147.23 -2.20 .03 
  Tx*Leg2* DERS goals 1.10 .49 158.13 2.25 .02 
 BMI Tx*Leg2*DERS goals -.20 .11 175.78 -1.70 .09 
DERS 
Impulse 
EDI-BD Tx*Leg1* DERS impulse -.57 .33 147.23 -1.72 .08 
DERS 
aware 
EDI-Bulimia  Tx*Leg1* DERS aware -.69 .37 150.30 -1.87 .06 
DERS 
Clarity 
EDI-DT Tx*Leg1* DERS clarity -.70 .35 150.75 -2.00 .04 
 EDI-Bulimia  Tx*Leg1* DERS clarity -1.03 .41 148,87 -2,55 .01 
 EDI-BD Tx*Leg1* DERS clarity -.76 .38 142.55 -1.98 .04 
DDS total EDI-Bulimia  Tx*Leg2* DDS total -.58 .29 160.53 -1.99 .04 
 EDI-BD Tx*Leg1* DDS total .35 .21 148.41 1.70 .09 
EATDS 
freq 
EDE-Restraint Tx*Leg1* EATDS Freq   .05 .02 165.68 2.25 .02 
 EDE-Global  Tx*Leg1* EATDS Freq .03 .02 165.12 1.73 .08 
 EDI-Bulimia  Tx*Leg1* EATDS Freq -1.03 .41 148.87 -2.55 .01 
 BMI Tx*Leg2* EATDS Freq -.06 .03 173.84 -1.71 .08 
EATDS 
defuse 
EDE-Restraint Tx*Leg1* EATDS Defuse -.06 .03 155.23 -2.15 .03 
 EDI-Bulimia  Tx*Leg1* EATDS Defuse .35 15 138.40 2.41 .01 
 EDI-BD Tx*Leg1* EATDS Defuse .35 .15 138.40 2.41 .01 
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Figure 1: CONSORT flow-chart 
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Figure 2: Graphs of Outcome Variables 
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Figure 3: Diagnostic Status as a Moderator of EDE Restraint Scores 
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